PharmaCyte Biotech Inc (PMCB)

[frosr6]

Item 2.01 Completion of Acquisition or Disposition of Assets

On August 31, 2005, the company completed the acquisition of MedElite, Inc. from Dr. Richard Goldfarb for ten million shares of the company’s common stock, plus potential bonuses of restricted shares if certain sales/revenue benchmarks are achieved. MedElite distributes clinically proven products to physicians who then prescribe the products for their patients. It is the exclusive U.S. distributor of the Talsyn™ product line that has been clinically proven to facilitate and improve the appearance, redness and strength of scars.

A copy of the Share Purchase Agreement is attached as an exhibit.
Dr. Goldfarb will continue as the President and Chief Executive Officer of the company’s MedElite subsidiary. Dr. Goldfarb has been engaged in private practice as a general, vascular and trauma surgeon for 13 years in the Philadelphia area; he lectures on pertinent health issues and conducts research and development of various health and medicinal products. Dr. Goldfarb serves as the Medical Director of Research ad Development for the FDA-approved Bucks County Clinical Research Center (http://bccrinc.com), which has performed over 270 clinical trials during its 27 years of existence for many major pharmaceutical companies, including Abbott Laboratories, Hoffman-LaRoche, Inc. Eli Lilly and Company, Pfizer, Inc. and Sankyo/Upjohn.

SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
EFOODSAFETY.COM, INC.
(Registrant)
Date: September 6, 2005
-------------------------------------
Patricia Ross-Gruden, President and
Chief Executive Officer


http://www.wikinvest.com/stock/eFoodSafety.com_(EFSF)/Completion_Acquisition_Disposition_Assets